Weibo Du
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
Papers in
- Hepatology 13
- Liver Disease and Transplantation 8
- Liver physiology and pathology 3
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Hepatitis B Virus Studies 3
- Influenza Virus Research Studies 2
- Co-authors
- Lanjuan Li (15 shared papers)Xiaoping Pan (9 shared papers)Cao Hongcui (9 shared papers)Wenbiao Chen (4 shared papers)Yu Liang (1 shared paper)Juan Lu (1 shared paper)Chengbo Yu (6 shared papers)Jianrong Huang (3 shared papers)
In The Last Decade
Weibo Du
27 papers receiving 564 citations
Peers
Comparison fields: 5 of 65
- Hepatology 221
- Biological Psychiatry 8
- Epidemiology 124
- Obstetrics and Gynecology 25
- Infectious Diseases 44
Countries citing papers authored by Weibo Du
This map shows the geographic impact of Weibo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Du more than expected).
Fields of papers citing papers by Weibo Du
This network shows the impact of papers produced by Weibo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Du. The network helps show where Weibo Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibo Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 57 | |
| 2 | 2012 | 49 | |
| 3 | 2020 | 46 | |
| 4 | 2013 | 43 | |
| 5 | 2011 | 42 | |
| 6 | 2014 | 38 | |
| 7 | 2024 | 38 | |
| 8 | 2011 | 31 | |
| 9 | 2014 | 30 | |
| 10 | 2015 | 30 | |
| 11 | Prognostic models for acute liver failure. | 2010 | 29 |
| 12 | 2007 | 22 | |
| 13 | 2010 | 18 | |
| 14 | 2012 | 17 | |
| 15 | 2022 | 17 | |
| 16 | 2015 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2009 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 2019 | 11 |
About Weibo Du
Weibo Du is a scholar working on Hepatology, Epidemiology, Pharmacology, Surgery and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 588 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (8 papers), Tissue Engineering and Regenerative Medicine (4 papers), Liver physiology and pathology (3 papers), Hepatitis B Virus Studies (3 papers), Influenza Virus Research Studies (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Hepatology (221 citations), Biological Psychiatry (8 citations), Epidemiology (124 citations), Obstetrics and Gynecology (25 citations) and Infectious Diseases (44 citations). Weibo Du has collaborated with scholars based in China, Australia and Canada. Frequent co-authors include Lanjuan Li, Xiaoping Pan, Cao Hongcui, Wenbiao Chen, Yu Liang, Juan Lu, Chengbo Yu, Jianrong Huang, Yuemei Chen and Minglin Ou. Their work appears in journals such as Journal of Hepatology, PLoS ONE, Epigenomics, International Journal of Infectious Diseases and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.